Kite Pharma Garners $127,500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=433004bf-081c-40af-99aa-addd8af3bcee - Date
6/19/2014 - Company Name
Kite Pharma - Mailing Address
2225 Colorado Avenue Santa Monica, CA 90404 USA - Company Description
Kite Pharma, Inc. (NASDAQ: KITE) is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells. - Website
http://www.kitepharma.com - Transaction Type
IPO - Transaction Amount
$127,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
